Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Natural Biocon (India)'s Enterprise Value is ₹115.77 Mil.
Natural Biocon (India)'s Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.00 Mil. Therefore, Natural Biocon (India)'s EV-to-FCF for today is .
The historical rank and industry rank for Natural Biocon (India)'s EV-to-FCF or its related term are showing as below:
BOM:543207'
s EV-to-FCF Range Over the Past 10 Years
Min: 0 Med: 0 Max: 790.3
Current: 790.3
During the past 12 years, the highest EV-to-FCF of Natural Biocon (India) was 790.30. The lowest was 0.00. And the median was 0.00.
BOM:543207's EV-to-FCF is ranked worse than 98.28% of 932
companies
in the Chemicals industry
Industry Median: 21.49
vs BOM:543207: 790.30
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Natural Biocon (India)'s PE Ratio (TTM) for today is calculated as:
Natural Biocon (India)'s share price for today is ₹4.36.
Natural Biocon (India)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.030.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Natural Biocon (India)'s EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Natural Biocon (India) EV-to-FCF vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Natural Biocon (India)'s EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Natural Biocon (India)'s EV-to-FCF falls into.
Natural Biocon (India)'s current Enterprise Value is ₹115.77 Mil.
Natural Biocon (India)'s Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is Natural Biocon (India) (BOM:543207) Overvalued in 2026?
Based on GuruFocus' analysis, Natural Biocon (India) stock appears to be overvalued.
The current stock price of ₹4.36 is trading 38% above its estimated GF Value™ of ₹3.16.
GuruFocus considers Natural Biocon (India) to be Significantly Overvalued.
Key valuation signals for BOM:543207:
EV-to-FCF:
GF Value™: ₹3.16 vs. price of ₹4.36 (38% above fair value)
No single metric tells the full story. See the BOM:543207 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Natural Biocon (India) Ltd is engaged in the business of chemicals, natural extracts, and agricultural products. The company manufactures natural food colors. Its revenue stream is retail trading of commodities, which are generated through the sale of chemicals in Ahmedabad and Mumbai. The company generates revenue and operates within India.
69GF Score
Get the complete analysis for BOM:543207
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543207 has been successfully added to your 
